SignalCorporate
Milestone Pharmaceuticals GAAP EPS of -$0.18 beats by $0.04, revenue of $2.96M beats by $1.96M
Milestone Pharmaceuticals beat EPS and revenue estimates, with revenue $1.96M above consensus.
What changed
Milestone Pharmaceuticals beat EPS and revenue estimates, with revenue $1.96M above consensus.
Why it matters
Milestone Pharmaceuticals beat EPS and revenue estimates, with revenue $1.96M above consensus. — impact context not separately stored; see What changed.